| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |